Biotechnology

Shuttle Pharmaceuticals

Shuttle Pharmaceuticals released FY2026 Q1 earnings on May 15 (EST) with actual revenue of USD 0 and EPS of USD -0.43

Shuttle Pharmaceuticals released FY2025 earnings on March 31 (EST) with actual revenue of USD 0 and EPS of USD -7.1599

Shuttle Pharmaceuticals released FY2025 Q4 earnings on March 31 (EST), actual revenue USD 0, actual EPS USD -0.9461

Shuttle Pharmaceuticals Holdings Announces Termination of Second Phase Clinical Trials for Ropidoxuridine

Shuttle Pharmaceuticals released FY2025 Q3 earnings on November 13, 2025 (EST), with actual revenue of USD 0 and EPS of USD -1.0508

Shuttle Pharmaceuticals released FY2025 9 Months Earnings on November 13, 2025 (EST) with actual revenue of USD 0 and EPS of USD -11.9377

Shuttle Pharmaceuticals Advances Ropidoxuridine and Plans to Acquire Molecule.ai

Shuttle Pharmaceuticals released FY2025 Semi-Annual Earnings on August 13 Post-Market (EST), Actual Revenue USD 0, Actual EPS USD -8.8241

Shuttle Pharmaceuticals released FY2025 Q2 earnings on August 13 (EST) with actual revenue of USD 0 and EPS of USD -3.2915

Shuttle Pharmaceuticals Holdings Completes $4.25 Million Private Placement Financing

Shuttle Pharmaceuticals Holdings Completes Private Placement Financing Raising $4.25 Million

Shuttle Pharmaceuticals Holdings Completes Private Placement

Shuttle Pharma Announces Improvement in Cancer Radiotherapy Outcomes

Shuttle Pharmaceuticals Updates on Second Phase Clinical Trial Progress for Glioblastoma

Shuttle Pharmaceuticals released FY2025 Q1 earnings on May 8 (EST) with actual revenue of USD 0 and EPS of USD -7.5953

Shuttle Pharmaceuticals Submits Provisional Patent Application for PSMA-Targeted PARP Inhibitor Conjugate for Precision Cancer Treatment

Shuttle Pharmaceuticals released FY2024 earnings on February 26, 2025 (EST), with actual revenue of USD 0 and EPS of USD -82.6

Shuttle Pharmaceuticals released FY2024 Q4 earnings on February 26, 2025 (EST), actual revenue USD 0, actual EPS USD -9.9841

Shuttle Pharmaceuticals released FY2024 Q3 earnings on November 13 (EST) with actual revenue of USD 0 and EPS of USD -39.8307

Shuttle Pharmaceuticals released FY2024 9 Months Earnings on November 13, 2024 (EST) with actual revenue of USD 0 and EPS of USD -84.6519

Amesite

InMed Pharmaceuticals

Meiwu Tech

Co-Diagnostics

Phoenix Asia

Generation Income Properties

Rubico

MetaVia

Virax Biolabs

Agilysys

SHPH

Earnings Watch

Shuttle Pharmaceuticals | 10-Q: FY2026 Q1 Revenue: USD 0

Shuttle Pharmaceuticals（SHPH.US）现价 $1.129，当日 +9.61%，盘中短线飙升，市值 0.06 亿。医疗开发企业，因宣布与狗狗币矿商 United Dogecoin 合并引发股价大幅波动。近期涉及加密矿业合作，板块资金活跃，市场短线交易情绪高涨。

Movers Alert

Shuttle Pharma (SHPH.US) Gains 9% Intraday on Merger

TXXD

GDOG

Shuttle Pharmaceutical Holdings, Inc. (NASDAQ: SHPH) has announced a merger with United Dogecoin Inc., creating the largest publicly listed Dogecoin mining company. The merger, supported by an $11 million PIPE financing, aims to enhance mining capacity with new ElphaPex Mining Rigs. CEO Ryan Trasolini emphasizes a dual strategy of efficient mining and holding mined Dogecoin for long-term value. The merger will result in United Dogecoin becoming a wholly-owned subsidiary of Shuttle, with Trasolini appointed as co-CEO. The deal includes convertible preferred stock and warrants for United Dogecoin's equity holders.

StockTitan

21Shares 2x Long Dogecoin ETF

Grayscale Dogecoin Trust ETF

Bitwise Dogecoin ETF

Nano Labs

First Trust Eurozone AlphaDex

First Trust Germany

I-PEX Inc.

American Bitcoin

BTC Development

Bitcoin Depot

Hut 8 Mining

Aaon

American Century Small Cp Val Insgts ETF

Athena Bitcoin Global

Irobot

Robot Home, Inc.

Roblox

BTC Development - Unit

BTC DEVELOPMENT CORP C/WTS 11/09/2030 (TO PUR COM)

BITCOIN DEPOT INC C/WTS 30/06/2028(TO PUR COM)

IROBOT CORP

United Dogecoin Goes Public in Landmark Merger, Powering a Scaled, Next Generation DOGE Mining Operation | SHPH Stock News

AKAN

SMMT

SENS

In Thursday's after-market session, Cue Biopharma (CUE) shares surged 45.1% to $21.5, while Shuttle Pharmaceuticals (SHPH) rose 25.96% to $1.31. Other gainers included Akanda (AKAN) up 24.59% to $61.0 and Emergent BioSolutions (EBS) up 10.93% to $9.13. Conversely, Summit Therapeutics (SMMT) fell 24.1% to $16.3, and Senseonics Holdings (SENS) dropped 16.8% to $5.5. Overall, several companies reported Q1 earnings, influencing stock movements.

benzinga_article

Cue BioPharma

Emergent Biosolutions

Akanda

Summit Therapeutics

Senseonics

Cerus

American Shared Hosp

Calidi Biotherapeutics

Prelude Therapeutics

Guardian Pharmacy Services

OSR HOLDINGS INC C/WTS 09/02/2028 (TO PUR COM)

12 Health Care Stocks Moving In Thursday's After-Market Session

BWOW

Shuttle Pharmaceuticals Holdings shares are trading higher after the company announced it entered into a definitive merger agreement to acquire United Dogecoin.

COHR

Shuttle Pharmaceuticals pre-market down 8.66%; Coherent Corp. pre-market up 3.48%; Cyclerion Therapeutics pre-market up 148.39%; Binah Capital pre-market up 59.22%; RenX Enterprises pre-market up 36.52%

Price Alert

Coherent Corp.

Pre-market hot trades in US stocks: Shuttle Pharmaceuticals down 8.66% pre-market; Coherent Corp. up 3.48% pre-market

ASTC

ITRM

MKDW

In the past hour, the overall market in the U.S. stock market has shown significant divergence, with technology stocks and small-cap stocks performing particularly well. Astrotech's surge of 167.93% has attracted widespread attention in the market, driving the activity of related technology stocks. Meanwhile, several stocks in the pharmaceutical sector have also performed well, with Iterum Therap and MKD Tech rising by 106.74% and 60.08%, respectively, and their trading volumes significantly increasing, indicating strong capital interest. In contrast, some green energy and financial stocks have faced considerable pressure, with Roma Green Finance dropping sharply by 58.57%, reflecting market sentiment fluctuations. The stock with the largest movement in the past hour, Astrotech, saw its price soar to 167.93% in a short period, reaching a new 60-day high, with market sentiment running high and noticeable capital inflow. The strong performance of this stock seems to have attracted a large amount of short-term capital, energizing the entire technology sector. Strong stocks: 1. Iterum Therap: up 106.74%, with increased trading volume, driven by optimistic market sentiment about its future prospects, leading to a rapid rise in stock price. 2. MKD Tech: up 60.08%, with an influx of short-term capital making the stock stand out during the session, attracting the attention of many investors. 3. Greenland Energy: up 52.26%, this stock has been favored by the market against the backdrop of energy transition, with significantly increased trading volume

Astrotech

Iterum Therap

MKD Tech

Roma Green Finance

Greenland Energy

Urban-Gro

EpicQuest Edu

Quantum Biopharma

Southland

DNA X

OceanPal

System1

Lantern Pharma

Ridgetech

Mangoceuticals

Next Tech

Robin Energy - WI

Sobr Safe

Fast Track

High-Trend

Innovate

Turbo Energy SA

22nd Century

TruGolf

Cognition Therapeutics

Agape ATP

Polaryx Therapeutics

United Therap

MMTEC

Paranovus ENT Tech

Applied Optoelectronics

U Power

Swarmer

Founder

Boxlight

Jinxin Tech

Delixy

Abits

Luda Tech

Jaguar Uranium

Aeries Tech

AEON Biopharma, Inc.

Sysco

MOUNTAIN LAKE ACQUISITION CORP COM USD0.0001 CL A (SUB/RIGHTS) 15/11/28

FGI Industries

Century Aluminum

Beachbody

Rani Therapeutics

Chanson

Alcoa

NextTrip

Trio Petroleum

Enigmatig

SUNation Energy

Falcon Beyond Global

Kopin

Solo Brands

Opendoor Tech Series K - CW26

Veritone

Robinhood Ventures Fund I

Corvex

Bloom Energy

Newsmax

PRF Tech

Insight Molecular Diagnostics

Boqii

ImageneBio

Cibus

Globavend

ENvue Medical

Axe Compute

Origin Agritech

Carvana

Texxon

Applied Digital

Fabrinet

Streamex

ImmunityBio

EON Resources

ITERUM THERAPEUTICS PLC

U.S. stock market movement update: Astrotech surged 167.93%, Iterum Therap rose 106.74%, with multiple stocks experiencing increased trading volume; Roma Green Finance fell 58.57%, and Skycorp Solar dropped 45.70%!

Shuttle Pharmaceuticals Holdings, Inc. (NASDAQ: SHPH) has launched an advanced version of its molecule.ai platform, enhancing its capabilities in therapeutic discovery. The update introduces new models for evaluating and prioritizing therapeutic candidates, integrating predictive and generative capabilities. Additionally, a next-generation autonomous AI agent system is unveiled, enabling multi-step reasoning and orchestration across scientific workflows. This innovation aims to reduce timelines and costs in drug development, positioning Shuttle Pharma as a leader in AI-driven biopharma innovation.

VG Health

Proshares Ultra Nasdaq Biotech

iShares Global Healthcare

Direxion S&P Biotech Bull 3X

SPDR S&P Biotech

Invesco Biotechnology & Genome ETF

First Trust NYSE Arca Biotech Index Fd

Ark Genomic Revolution ETF

iShares Biotechnology ETF

iShares US Pharma

ALPS Medical Breakthrough

Health Care Select Sector SPDR

VanEck Biotech ETF

Shuttle Pharmaceuticals Launches Autonomous Self Reasoning AI Agent for Scientific Workflows | SHPH Stock News

Shuttle Pharmaceuticals(SHPH.US)